1.9500
18-February-25 10:48:26
15 minutes delayed
Stocks
+0.0600
+3.17%
Today's range
1.8500 - 1.9500
ISIN
N/A
Source
NASDAQ
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
30 Jan 2025 06:00:00 By Nasdaq GlobeNewswire